* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 1,916 · FY2023 2,000 · FY2024 2,474 — 3-yr total 6,389
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2024 annual report, the group operates as a treatment and diagnostic medical facility. Parent company of a consolidating group, established 1991. Focus on early complex diagnosis and treatment.
Group parent — controls 2 companies · ownership
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| 10,820 | 17,407 | 22,614 | 25,831 | 17,181 | 24,116 | 30,483 | 31,653 | +16.6% | |
| 67,092 | 71,803 | 74,989 | 86,792 | 108,323 | 119,108 | 129,261 | 155,428 | +12.8% | |
| TOTAL ASSETS | 77,913 | 89,210 | 97,603 | 112,623 | 125,504 | 143,224 | 159,743 | 187,081 | +13.3% |
| 2,246 | 2,651 | 2,599 | 6,631 | 4,369 | 10,300 | 9,005 | 7,235 | +18.2% | |
| 2,869 | 1,626 | 0 | 0 | 0 | 0 | 0 | 1,709 | -7.1% | |
| TOTAL LIABILITIES | 5,115 | 4,277 | 2,599 | 6,631 | 4,369 | 10,300 | 9,005 | 8,944 | +8.3% |
| 72,797 | 84,933 | 95,004 | 105,992 | 121,135 | 132,924 | 150,739 | 178,137 | +13.6% | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | |||||||||
| Total Debt | 4,014 | 2,419 | 0 | 0 | 0 | 6,510 | 4,676 | 3,612 | -1.5% |
| Cash & Equivalents | 2,801 | 4,041 | 3,639 | 7,244 | 5,247 | 8,541 | 13,426 | 10,399 | +20.6% |
| Net Debt | 1,213 | 1,622 | 3,639 | 7,244 | 5,247 | 2,031 | 8,750 | 6,787 | nmf |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →